Natural killer cells and natural killer-T cells in patients with renal transplantation;Natürliche killerzellen und natürliche killer-T-zellen bei nierentransplantation

LaboratoriumsMedizin

Volumn 32, Issue 3, 2008, Pages 140-147

  Hoppe, Anett ^a   Kamprad, Manja ^a,b   Wegmann, Claudia ^a   Wötzel, Michael ^c   Hauss, Johann ^a   Emmrich, Frank ^a,b   Fangmann, Josef ^a   Sack, Ulrich ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^c Labor Reisig Ackermann   (Germany)

Author keywords

Flow cytometry; Natural killer cells; Natural killer T cells; Transplantation

Indexed keywords

BASILIXIMAB; CD16 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR3; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISOLONE; PROTEIN P30; PROTEIN P44;

ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; STATISTICAL ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 44949169877     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2008.030     Document Type: Article

References (34)

1. Kuypers DR. Kidney transplantation: current issues and future prospects. Acta Clin Belg 2007;62:208-17.
2. Oliveira JG, Monteiro MS, Teixeira JF, Osório E, Norton SM, Alves H, et al. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment. Transpl Int 2005;18:1286-91.
3. Moll S, Pascual M. Humoral rejection of organ allografts. Am J Transplant 2005;5:2611-8.
4. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005;56:23-46.
5. Walzer T, Jaeger S, Chaix J, Vivier E. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 2007;19:365-72.
6. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, et al. Recognition of peptide-MHC class I complexes byactivating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005;102:13224-9.
7. Feng J, Xie Z, Yu M, Gou N, Shen B. The difference of binding epitopes on human CD16 (FcgammaRIII) interacted with hIgG1 and monoclonal antibody B88-9. Mol Immunol 2004;41:93-8.
8. Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur J Immunol 2004;34:81-90.
9. Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Peña J, et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2001;38:637-60.
10. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003;100:8856-61.
11. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today 2000;21:228-34.
12. Bottino C, Moretta L, Pende D, Vitale M, Moretta A. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol Immunol 2004;41:569-75.
13. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006;214:73-91.
14. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 2007;19:354-64.
15. Jukes JP, Wood KJ, Jones ND. Natural killer T cells: a bridge to tolerance or a pathway to rejection? Transplantation 2007;84:679-81.
16. Lazzeri E, Romagnani P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:109-18.
17. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ. Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant 2004;4:432-7.
18. Zand MS. Immunosuppression and immune monitoring after renal transplantation. Semin Dial 2005;18:511-9.
19. Augustine JJ, Hricik DE. Minimization of immunosuppression in kidney transplantation. Curr Opin Nephrol Hypertens 2007;16:535-41.
20. Cross TJ, Berry PA, Burroughs AK. Infection in solid-organ transplant recipients. N Engl J Med 2008;358:1302.
21. Weimann A, Eisele RM, Pawellek S, Hippler-Benscheid M, Rüggeberg A, Cammann H, et al. Diagnostic value of peripheral blood markers for acute rejection in LTX-patients receiving anti IL-2R antibodies. J Lab Med 2008 (im Druck).
22. Burton RC, Cosimi AB, Colvin RB, Rubin RH, Delmonico FL, Goldstein G, et al. Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation. J Clin Immunol 1982;2:142S-7S.
23. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005;11:234-8.
24. Molter GP, Soltesz S, Kottke R, Wilhelm W, Biedler A, Silomon M. Procalcitoninplasmakonzentration und systemische inflammatorische Antwort nach verschiedenen operativen Eingriffen. Anaesthesist 2003;52:210-7.
25. Xia G, Ji P, Rutgeerts O, Waer M. Natural killer cell- and macrophage mediated discordant guinea pig→rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity. Transplantation 2000;70:86-93.
26. Maier S, Tertilt C, Chambron N, Gerauer K, Huser N, Heidecke CD, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001;7:557-62.
27. Toubert A, Dulphy N, Tieng V, Tamouza R, Charron D. Natural killer lymphocyte activation in response to stress. Transfus Clin Biol 2003;10:109-12.
28. Esterling BA, Kiecolt-Glaser JK, Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom Med 1996;58:264-72.
29. Cantoni C, Ponassi M, Biassoni R, Conte R, Spallarossa A, Moretta A, et al. The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure 2003;11:725-34.
30. Flieger D, Spengler U, Beier I, Kleinschmidt R, Hoff A, Varvenne M, et al. Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines. Hybridoma 1999;18:63-8.
31. Solà R, Vela E, Cleries M, Guirado LI, Díaz JM, Facundo C, Deulofeu R. Living donor kidney transplantation in catalonia: comparison with cadaveric kidney donors. Transplant Proc. 2007;39:2208-9.
32. Seron D, O'valle F, Moreso F, Goma M, Hueso M, Grinyo JM, et al. Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus- versus cyclosporine-treated patients. Transplantation 2007;83:649-52.
33. Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, et al. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. Transpl Int 2006;19:657-66.
34. Kang YN, Oh HK, Chang YC, Kim HC, Lee SL, Hwang M, et al. Systemic herpes simplex virus infection following cadaveric renal transplantation: a case report. Transplant Proc 2006;38:1346-7.